Historically viewed as recession-proof, 2023 is expected to be a challenging year for the healthcare industry as macroeconomic factors – inflation, high labor expenses, volatile markets, supply chain snarls and other issues – exert their influence in ways not previously seen, according to McDermott Will & Emery’s Healthcare practice. In addition, healthcare providers – including hospitals and health systems – must grapple with the end of the COVID-19 public health emergency (PHE), which will require unwinding the multi-layered changes that were put into effect during the PHE. Read more.
Related Posts
Telehealth will Endure, but Providers are Managing Expectations
The survey of 240 healthcare providers showed a majority (69%) consider telehealth to be convenient, but another 28% described virtual care as frustrating.
March 23, 2022
Two Factors Impacting Home Health M&A In 2023
One affects the seller and the other affects the buyer. Each is largely out of home health providers’ hands.
January 20, 2023
AMA, MGMA Call for HHS to Hold Off on $100M in Provider Relief Clawbacks
The Department of Health and Human Services (HHS) is clawing back as much as $100 million in pandemic assistance from healthcare providers who didn’t comply with the agency’s reporting requirements.
April 4, 2022
Scaling Physician Practices to Increase Value
Private practices can more easily meet growing demand while retaining clinical autonomy. Meanwhile, investors can help improve the operations of an essential industry and expand access to communities across the country.
September 30, 2022